市场调查报告书
商品编码
1210897
全球宏基因组学市场规模研究与预测:按技术、产品、应用、工作流程和地区分析,2022-2029 年Global Metagenomics Market Size study & Forecast, by Technology by Product, by Application, by Workflow and Regional Analysis, 2022-2029 |
2021 年全球宏基因组市场价值约为 14.6 亿美元,预计在 2022-2029 年预测期内将以超过 14.0% 的健康增长率增长。
宏基因组学使用全基因组测序来研究自然环境中所有微生物群成员的完整基因组成。 宏基因组分析是一个专注于对从人类消化道(肠道菌群)和地热温泉等各种栖息地分离的微生物基因组进行直接遗传分析的领域。 由于测序成本下降、生物技术和生物信息学技术的进步以及对用于各种研究的微生物筛选的兴趣增加等因素,宏基因组学市场正在扩大。
这是由于技术突破、研发支出增加、测序成本下降以及宏基因组学知识的增加。 此外,对生物信息学的投资以支持宏基因组学和微生物组分析,以及研究人员对宏转录组学、代谢组学和宏蛋白质组学领域的兴趣日益浓厚,这些发展是推动市场扩张的其他因素。是的一部分 例如,SeqOne 在 2022 年 1 月筹集了 2000 万欧元的 A 轮融资。 对开发下一代基因组学和生物信息学的公司的投资越来越多。 此外,人们对病毒性腹泻、流感、乙型肝炎和 HIV/AIDS 等病毒性疾病的兴趣日益浓厚,以及被发现的基因数量不断增加,这些都催生了新的宏基因组研究产品。 联合国艾滋病署估计,到 2022 年全球将有 3770 万艾滋病病毒感染者。 自疫情开始以来,已有7930万人感染了艾滋病毒。 新感染艾滋病毒的人数下降了 52%。 大约有 150 万人新感染了艾滋病毒。 因此,病毒性疾病流行率的上升正在为市场创造有利可图的增长。 然而,宏基因组学的高成本将阻碍整个 2022-2029 年预测期内的市场增长。
全球宏基因组学市场研究考虑的主要区域包括亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 在这些地区中,由于老年人口增加、慢性病预防率上升以及该地区主要市场参与者数量增加等因素,北美所占份额最大。 此外,由于目标人口增加和该地区研发活动增加等因素,预计亚太地区将出现显着增长。
这项研究的目的是揭示近年来各个细分市场和国家/地区的市场规模,并预测未来几年的市场规模。 该报告旨在捕捉被调查国家工业的定性和定量方面的情况。
它还提供了关键方面的详细信息,例如决定市场未来增长的驱动因素和挑战。 此外,它还包含供利益相关者投资的微观市场潜在机会,以及对主要参与者的竞争格局和技术产品的深入分析。
Global Metagenomics Market is valued approximately USD 1.46 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 14.0% over the forecast period 2022-2029. Metagenomics is the study of the full genetic makeup of every microbiota member in a natural environment using the whole genome sequencing method. Metagenomics is a field that focuses on the direct genetic analysis of microbial genomes that have been isolated from a variety of habitats, including the human gastrointestinal tract (gut microbiome) and geothermal hot springs. The Metagenomics market is expanding because of factors such as rising declining expenses of sequencing, developments in biotechnology & bioinformatics techniques and rising interest in microbial screening for different investigations.
Technological breakthroughs, rising research and development spending, falling sequencing costs, and increased knowledge of metagenomics are all credited. In addition, investments in bioinformatics to support metagenomics and microbiome profiling as well as researchers' increased interest in the fields of meta transcriptomics, metabolomics, and metaproteomics as well as these developments are some other drivers boosting the market's expansion. As an example, SeqOne raised EUR 20 million in a Series A round in January 2022. Growing investments are now being made in firms that are developing the next generation of genomics and bioinformatics. Furthermore, New metagenome study products have been created as a result of growing worries about viral diseases such virus-induced diarrhoea, influenza, hepatitis B, and HIV/AIDS as well as an increase in the number of genes being discovered. United Nations AIDS estimates that 37.7 million individuals worldwide with HIV as of 2022. Since, the onset of the epidemic, 79.3 million people have contracted HIV. The number of new HIV infections has fallen by 52%. And there were almost 1.5 million new HIV infections. Thus, rising prevelance of viral diseases is creating a lucrative growth to the market. However, the high cost of Metagenomics stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Metagenomics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. Among these region, North America holds the largest share owing to factors such as rising geraiticgeriatric population, rising prevelanceprevalence of chronic disease and rising number of key market players in the region. Furthermore, Asia Pacific region is expected to grow at a significant rate owing to factors such as rising target population, and rising research and development activities in the region.
Major market players included in this report are:
Bio-Rad Laboratories
Illumina, Inc.
PerkinElmer, Inc.
Thermo Fisher Scientific, Inc.
Novogene Co., Ltd.
Promega Corporation
QIAGEN
Takara Bio, Inc.
Oxford Nanopore Technologies
F. Hoffmann-La Roche Ltd.
Recent Developments in the Market:
Global Metagenomics Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Technology, Product, Application, Workflow, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Technology offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Shotgun Sequencing
16S Sequencing
Whole Genome Sequencing
Others
By Product:
Kits and Reagents
Sequencing & Data Analytics Services
Software
Application:
Environmental Application
Clinical Diagnostics Applications
Drug Discovery Applications
Biotechnology Applications
Food & Nutrition Applications
Other Application
By Workflow:
Pre-sequencing
Sequencing and Data Analysis
Product:
Human Metagenomics
Metagenomics Analog
By Distribution Channel:
Hospitals
Retail Pharmacies
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable